More recent discoveries, such as the ability to measure isoprostanes, may help to better quantify the level of OxS and permit analyses related to antioxidative defenses in humans.
Urinary 8,12-iso-iPF2α-VI 8,12-iso-iPF2α-VI 8,12-iso-iPF2α-VI 8,12-iso-iPF2α-VIxy-guanosisoprostanedGuo) levels [ 22] were meandred 8-oxo-7,8-dihydro-2′-deoxy-guanosine 8-oxo-7,8-dihydro-2′-deoxy-guanosine 8-oxo-7,8-dihydro-2′-deoxy-guanosine 8-oxo-7,8-dihydro-2′-deoxy-guanosine 8-oxo-7,8-dihydro-2′-deoxy-guanosine 8-oxo-7,8-dihydro-2′-deoxy-guanosine 8-oxo-7,8-dihydro-2′-deoxy-guanosine
Isoprostane levels however, are not affected by diet [55] and may be a better measure of oxidative stress [56].
It is therefore suggested that, in the studied diabetic patients, although the production of isoprostanes in the body was increased (as other plasma oxidative stress biomarkers were altered) it did not lead to an increase in plasma isoprostane levels.
Results: We found increased plasma and urine MDA in the diabetic patients and almost significantly decreased plasma vitamin E. Urinary isoprostane levels in diabetic patients were increased but they presented a strong tendency to a decrease in plasma isoprostanes.
Surprisingly, we found that resveratrol significantly raised the levels of F2-isoprostanes in the heart relative to controls (P<0.05) and isoprostane levels in the brain were higher in resveratrol treated mice compared CR mice (P<0.01); isoprostane levels were similar among groups in muscle.
Urinary isoprostane levels were normalized against creatinine concentration.
Urinary isoprostane levels were determined using a urinary isoprostane F2t ELISA kit (JaICA, Fukuroi, Japan), according to the manufacturer's instructions.
We compared these concentrations with isoprostane levels in the three categories within each group.
Prior to analysis of isoprostane levels urine samples were hydrolyzed and affinity purified.
